Cognition Therapeutics
CGTX
CGTX
75 hedge funds and large institutions have $16.3M invested in Cognition Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 78 → 75 (-3)
44% less capital invested
Capital invested by funds: $29M → $16.3M (-$12.8M)
Holders
75
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$233K | |
| 2 | +$185K | |
| 3 | +$178K | |
| 4 |
Renaissance Technologies
New York
|
+$172K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$142K |
Top Sellers
| 1 | -$284K | |
| 2 | -$215K | |
| 3 | -$205K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$157K |
| 5 |
VC
Voss Capital
Houston,
Texas
|
-$92.4K |
